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Circadian clock mechanismMost internationally travelled researchers will have encountered jetlag. If not, working odd hours
makes most of us feel somehow dysfunctional. How can all this be linked to circadian rhythms
and circadian clocks? In this review, we deﬁne circadian clocks, their composition and underlying
molecular mechanisms. We describe and discuss recent crystal structures of Drosophila and mam-
malian core clock components and the enormous impact they had on the understanding of circa-
dian clock mechanisms. Finally, we highlight the importance of circadian clocks for the daily
regulation of human/mammalian physiology and show connections to overall ﬁtness, health and
disease.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
1.1. Circadian clocks and physiology
Most organisms from cyanobacteria to man have developed
endogenous circadian (that is about 24 h) biological rhythms [1–
7] in order to adapt to the geophysical day–night cycle. Many
human physiological functions and patterns of behavior underlie
circadian regulation by a so-called circadian clock. Examples
include sleep–wake rhythms, body temperature and blood pres-
sure, the production of hormones or the activity of the immune
system [8–11]. Additionally, a connection between circadian clocks
and cell cycle regulation as well as the control of genome stability
is becoming increasingly evident [12]. Disruption of circadian
rhythms (e.g. due to genetic mutations, frequent jet-lag or
shift-work) is linked to diverse pathogenic processes such as sleep
disorders, depression, metabolic syndrome, obesity, cardiovascular
diseases and even carcinogenesis [13–15] (Fig. 1A). Chronobiology
arose as a scientiﬁc ﬁeld to analyze these increasingly complex cor-
relations and this subsequently led to the development of
chronotherapy as a clinical application [16–18]. Furthermore, clock
modulating compounds have been identiﬁed [19,20] and their
potential use in the treatment of clock related and metabolic
disorders is under exploration.Circadian clocks and rhythms are synchronized to the environ-
ment by external stimuli (Zeitgeber signals), most importantly the
light–dark cycle of a day’s period, but also by temperature. In mam-
mals, the central oscillator (Pacemaker/Masterclock) is located in the
suprachiasmatic nucleus (SCN) of the brain’s hypothalamus.
Additionally, mammals possess peripheral clocks in nearly all of
their organs and tissues to generate local circadian rhythms in phys-
iology [21]. The central oscillator in the SCN is synchronized to the
environmental light–dark cycle via photic cues, which are detected
by the circadian photoreceptor melanopsin in the retinal ganglion
cells [22] and are transmitted to the SCN via the optic nerve. In
the SCN neurons, phosphorylation of the transcription factor CREB
activates the transcription of per1 and per2 clock genes [23,24].
This in turn serves as an input to the main transcriptional feedback
loop underlying the cell-autonomousmolecular circadian oscillator
(see below). Neuronal and humoral output signals of the SCN are
perceived as input signals by peripheral body clocks to orchestrate
circadian physiology and behavior in synchrony with the environ-
ment [21,15]. Different from the SCN master clock, peripheral body
clocks can also be synchronized by feeding rhythms as dominant
Zeitgeber signals. Irregular feeding rhythms may therefore lead to
an uncoupling of peripheral clocks from the SCN master clock,
which can affect ﬁtness and even health. Notably, in our modern
society, irregular food intake frequently arises from unusual
rest-activity cycles due to shiftwork or jetlag [25,13]. Aswewill dis-
cuss below, the mammalian molecular clockwork provides input
pathways to sense the cells metabolic, redox and energy states
Fig. 1. Circadian physiology and molecular clocks. (A) Schematic description of the circadian oscillator and its input and output pathways. The central oscillator (master
clock) time is set predominantly by light but also by temperature as environmental input signals (Zeitgeber). Oscillators in peripheral tissues (peripheral clocks) depend on
metabolic steering and signals of the master clock. The input signal is integrated by the core oscillator, which is operated by cell-autonomous transcriptional and translational
feedback loops. The endogenous 24 h period arises from the timely coordinated activation and repression of transcription, protein synthesis and degradation,
posttranslational and posttranscriptional modiﬁcations, protein interactions and changes in cellular localization. Output signals derived from clock controlled gene activation
(e.g. metabolic proteins, hormones) deﬁne circadian physiology and behavior as well as health balance. Imbalanced and dysfunctional states can lead to diseases like
metabolic syndrome, obesity, diabetes, cardiovascular disease, cancer, depression and sleep disorders. (B) Molecular oscillator of Drosophila melanogaster. The main feedback
loop including CLOCK (CLK) and CYCLE (CYC) as transcriptional activators and PERIOD (PER) and TIMELESS (TIM) as repressors is shown. In a second loop, VRI and PDP1
regulate the daily synthesis of CLOCK. Phosphorylation of PER and TIM (by kinases SGG, DBT, CK2, NEMO) as well as PER-TIM-(DBT) complex formation regulates their
stability and cellular localization. The E3 ligases SLIMB and JETLAG (JET) mediate PER and TIM proteasomal degradation. TIM degradation is triggered by light-dependent
interactions with the photoreceptor Cryptochrome (CRY). (C) Molecular oscillator of Mus musculus/mammals. The main feedback loop including CLOCK (CLK) and BMAL1 as
transcriptional activators and PERIOD 1,2,3 (PER1,2,3) and Cryptochrome 1,2 (CRY1,2) as repressors is shown. In a second loop, REV-ERB and ROR regulate the daily synthesis
of BMAL1. Phosphorylation of PERs and CRYs (only kinases CKI and AMPK are shown to reduce complexity) regulates their stability and cellular localization. BMAL1/CLOCK
phosphorylation affects their transcriptional activity. E3 ligases TrCP1/2 and FBXL3 mediate proteasomal degradation of PER and CRY. PER1/2-CRY1/2 complexes as well as
homo- and heterodimeric PER(1-3)-PER(1-3) complexes can be formed. (D) Daily transcriptional repression and activation cycles of the mammalian circadian clock. (1) In a
transcriptionally active state CLOCK/BMAL1 are bound to the E-box DNA and BMAL1 recruits CBP/p300. (2) In the early transcriptional repression phase (about CT12-CT20),
large complexes including CRY, PER and other factors, which affect chromatin structure and transcription termination (empty bulks), are recruited to BMAL1/CLOCK. (3)
During the late transcriptional repression phase (about CT0-CT4) a repressive DNA-bound BMAL1/CLOCK/CRY complex is formed. (1) Dissociation of CRY and recruitment of
CBP/p300 leads to reactivation of transcription at about CT8. CT = Circadian time; CT 0 = sunrise/light on/activity onset in diurnal organisms; CT 12 = sunset/light off. Fig. 1D
was adapted from [46].
T. Merbitz-Zahradnik, E. Wolf / FEBS Letters 589 (2015) 1516–1529 1517and their changes upon feeding and fasting. These input pathways
are sensitive e.g. to changes in cellular levels of NAD+ or ATP.
1.2. Molecular circadian clocks of Drosophila melanogaster and
mammals
In the model organisms D. melanogaster and mouse, that we
want to focus on in this review, the circadian oscillators have been
extensively analyzed at molecular level [26,6,7]. They are operated
by cell-autonomous gene-regulatory feedback loops with an
endogenous free-running period of roughly 24 h. The molecular
oscillators are composed of transcriptional activators and repres-
sors. Additionally, a number of proteins (e.g. kinases, phosphatases,
E3 ubiquitin ligases, (de)acetylases) post-translationally modify
their target proteins and thereby periodically regulate their tran-
scriptional activity, cellular localization, interactions, stability and
cellular concentration. Physiological outputs are generated by the
regulation of clock controlled genes (ccgs), which constitute
about 10% of all genes and vary in a tissue-speciﬁc manner. In
the following, key elements of the Drosophila and mammalian
circadian oscillators will be described (Fig. 1B and C).1.2.1. The Drosophila circadian oscillator
In the main gene regulatory feedback loop of the Drosophila cir-
cadian oscillator (Fig. 1B), the basic helix-loop-helix (bHLH) PAS
(PERIOD; ARNT; SINGLEMINDED) transcription factors dCLOCK
(dCLK) and dCYCLE (dCYC) form a heterodimer, which binds to
the E-box (enhancer box) promoter region of the clock genes period
(per, dPER) and timeless (tim, dTIM) and thereby activates their
expression [26,6]. The concentration of newly synthetized dPER
and dTIM proteins stays low to begin with, since protein accumula-
tion is delayed by their proteasomal degradation. dPER degradation
is initiated by phosphorylation through DOUBLETIME (DBT), a
homolog of casein kinase I (CKI), which leads to the recruitment
of the E3 ubiquitin ligase SLIMB. DBT phosphorylation in turn is
primed by the kinase NEMO [27–29]. After sunset (around circadian
time (CT) 12; see glossary for deﬁnition of CT), the cytosolic
concentrations of dPER and dTIM reach their highest level. dTIM
binds to the dPER-DBT complex and thereby stabilizes dPER.
Phosphorylation of dTIM by SHAGGY (SGG), a homolog of glycogen
synthase kinase 3 (GSK3), as well as dPER phosphorylation by
casein kinase 2 (CK2) promote nuclear entry of PER-TIM-DBT com-
plexes. In the nucleus, dTIM and dPER associate with and repress
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dPER and dTIM inhibit the expression of their own genes as well
as of ccgs affecting the ﬂies’ behavior, metabolism and development
[26,6]. Light-synchronization of the endogenous clock is mediated
by the circadian photoreceptor Drosophila cryptochrome (dCRY).
Upon light-exposure, dCRY undergoes a conformational change
enabling dTIM binding, which is followed by dTIM proteasomal
degradation via the E3 ubiquitin ligase JETLAG (JET) [30,31]. As
dTIM is sequestered from the feedback loop, the remaining free
dPER protein also is degraded following phosphorylation by DBT.
In that way, transcriptional repression is abolished and newly syn-
thesized dCLK can interact with continuously expressed dCYC to
activate transcription, which will restart the circadian cycle. The
daily rhythmic dCLK synthesis is controlled by a second intercon-
nected feedback loop, in which the basic leucin zipper (bZIP) tran-
scription factors PAR DOMAIN PROTEIN1 (PDP1) and VRILLE (VRI)
act as positive (PDP1) and negative (VRI) regulators of dclk gene
expression. The vri and pdp1 genes themselves are regulated by
dCLK/CYC [26,6].
1.2.2. The mammalian circadian oscillator
In the main feedback loop of the mammalian circadian oscilla-
tor (Fig. 1C), the heterodimeric bHLH-PAS transcription factors
BMAL1 and CLOCK (homologs of dCYC and dCLK) activate the tran-
scription of three period (mper1,2,3) and two cryptochrome
(mcry1,2) genes as well as many clock controlled genes (ccgs) that
determine circadian physiology and behavior [2,7]. Opposite to
dCLK and dCYC, mammalian BMAL1 is rhythmically expressed,
whereas CLOCK is continuously produced. Rhythmic BMAL1
expression is ensured by a second interconnected feedback loop,
in which two nuclear receptors, REV-ERB and ROR, repress
(REV-ERB) or activate (ROR) BMAL1 transcription. The rev-erb
and ror genes are also targets of BMAL1/CLOCK. Different from
dCRY, the mCRY proteins act as potent and light-independent tran-
scriptional repressors of the BMAL1/CLOCK complex. Hence, mam-
malian CRYs functionally replace Drosophila Timeless (dTIM) as
transcriptional repressors and binding partners of the PER proteins.
mCRY1/ knockout mice display a 1 h shorter and mCRY2/
knockout mice a 1 h longer period, while mCRY1/CRY2 double
knockout mice are totally arrhythmic [32–34]. Hence, mammalian
CRY1 and CRY2 are partially redundant, but also have
non-redundant clock functions. The mCRY repressor activity is
determined by posttranslational modiﬁcations (e.g. mCRY phos-
phorylation) as well as the daily rhythmic synthesis, degradation
and nuclear translocation of the mCRYs, which are controlled by
interactions with the E3 ubiquitin ligase FBXL3 and the mPER1/2
proteins. Interestingly, mCRY1 phosphorylation at Ser71 by
AMPK reduces mCRY1 stability by enhancing FBXL3 binding and
weakening mPER2 binding [35]. Since AMPK activity is regulated
by the AMP/ATP ratio in the cell, this provides a potential link
between the cells metabolic and energy state and the circadian
clock. Amongst the three mammalian PERIOD orthologues,
mPER1 and mPER2 constitute essential time keeping elements of
the central SCN master clock, whereas mPER3 only has a subtle
effect on the generation of behavioral rhythms [36]. Instead,
mPER3 appears to play a role in peripheral clocks and output func-
tions, since mPER3 disruption and human PER3 polymorphisms
lead to aberrant metabolic and sleep phenotypes [37,38]. Apart
from regulating mCRY stability and cellular localization, mPER pro-
teins participate in transcriptional regulation of BMAL1/CLOCK by
multifaceted mechanisms (discussed in detail below, Fig. 1D).
Mammalian PERs are phosphorylated by casein kinase I (CKI),
which affects their stability, protein interactions and nuclear
translocation. Additionally, casein kinase 2 (CK2) collaborates with
CKI in mPER2 degradation [39], and phosphorylation by GSK-3b
promotes mPER2 nuclear translocation [40]. CKI-dependentproteasomal degradation of mPER1 and mPER2 is mediated by
the E3 ubiquitin ligase ß-TrCP (ß-transducin repeat-containing
protein), the homolog of SLIMB [41,42]. Additionally, mPER2 [43]
and BMAL1 [44] are acetylated and their deacetylation is carried
out by Sirtuin1 (SIRT1). As SIRT1 is an NAD+ dependent enzyme,
the regulation of its enzymatic activity may provide an input path-
way for the clock to sense the cellular NAD+ concentration and
hence the cell’s metabolic and redox state.
Notably, there is a signiﬁcant and constantly increasing number
of additional molecular processes discovered that modulate the
pace of the Drosophila and mammalian circadian clock, including
e.g. further posttranslational modiﬁcations or posttranscriptional
effects, which we do not discuss because their complexity would
go far beyond the scope of this review. Instead, let us move on to
this review’s main intention: to present recent crystal structures
of Drosophila and mammalian clock proteins, the insights they pro-
vided and the follow-up experiments they inspired.2. Structural insights into Drosophila and mammalian circadian
clock regulation
2.1. PAS domains in PERIOD, CLOCK and BMAL1 clock proteins as
versatile interaction modules
The timely interaction of PAS (PERIOD-ARNT-SIM) domains and
LOV (Light-Oxygen-Voltage) domains (a subclass of sensory PAS
domains) is a recurring feature of circadian clock regulation. PAS
and LOV domains are present in transcriptional activator and
repressor proteins in the main gene regulatory feedback loop of
the fungal, ﬂy and mammalian circadian oscillators. Additionally,
they are present in the plant ZTL/FKF1/LKP2 photoreceptor family,
that tunes circadian rhythms and photoperiodic ﬂowering [45–47].
Apart from their dominant presence in circadian clock systems,
PAS and LOV domains have been identiﬁed in a large number of
signaling proteins mediating protein interactions or sensing envi-
ronmental signals such as light, redox potentials or the presence
of oxygen [48].
PAS domains consist of 120–150 residues arranged in a sheet of
ﬁve antiparallel ß-strands (herein referred to as bA – bE) and ﬂank-
ing a-helices (herein referred to as aA – aC) (Fig. 2). The helical
segments pack across one face of the ß-sheet forming a pocket that
frequently accepts ligands or sensory cofactors such as heme, FMN,
FAD, metabolites or divalent cations. In many PAS and LOV
domains, the remaining PAS ß-sheet surfaces are covered by addi-
tional elements (N-terminal caps or a-helices) located N- or
C-terminal to the PAS core domain, providing structural and func-
tional diversity to the overall theme [49,50]. PAS and LOV domains
are frequently coupled to other signaling modules such as
histidine- or serine/threonine kinases, phosphodiesterases, ion
channels or transcription factors, whose activity they modulate
in dependence of the signal they are able to sense [50].
Drosophila and mammalian PERIOD (d/mPER) clock proteins as
well as the mammalian bHLH-PAS transcription factors CLOCK,
NPAS2 and BMAL1 and their Drosophila homologs dCLOCK (CLK)
and dCYCLE (CYC) possess two PAS domains organized in tandem,
referred to as PAS-A and PAS-B (Fig. 2). In the PERIOD proteins, the
PAS domains mediate homodimer interactions, which likely mod-
ulate the functionality of more C-terminal regions of the molecule.
The latter include motifs that control the cellular localization or
stability of the PER proteins, posttranslational modiﬁcation sites,
regions involved in transcriptional regulation (e.g. the dCLK/CYC
inhibition domain (CCID) of dPER), binding sites for other clock
components (e.g. CKIe or CRY) as well as binding sites for mole-
cules that mediate physiological functions (e.g. nuclear receptors).
The PAS domains of the bHLH-PAS transcription factors mediate
Fig. 2. PERIOD, CLOCK and BMAL1: PAS domains and their versatile interplay. (A) Domain organization and crystal structure of Drosophila PERIOD (dPER) Top: domain
schematic of dPER. Two PAS domains (PAS-A and PAS-B) are N terminally preceded by CK2 and DBT phosphorylation sites. The latter contains Ser47, which (when
phosphorylated) mediates interaction with SLIMB for dPER degradation. The PAS-B domain predominantly binds dTIM (TIMELESS). The PAS-A domain also interacts with
dTIM and contains a long period mutation site (perL). A short period mutation site (perS) lies within the SM region, which is followed by the Per-SD (per-short downstream)
region. The SM and per-SD regions are extensively phosphorylated and can affect Ser47 phosphorylation. The CCID (dCLK:CYC inhibition domain) is involved in
transcriptional repression. Middle: Crystal structure of the dPER homodimer [56]. The dPER homodimer is stabilized by PAS-A-PAS-B interactions via the conserved Trp482.
Additionally, helix aF C-terminal to PAS-B binds to PAS-A of the dimerizing molecule. Helix aF adopts different conformations in the two dPER monomers. The SM- and Per-
SD regions are directly C-terminal to aF. dPER homodimer formation and changing aF conformations may therefore affect dPER stability by modulating phosphorylation
efﬁciency. Bottom: Close-up view of the PAS-A-aF homodimer interface. The perL (Val243Asp) mutation site and Met560 in helix aF opposite Val243, which was used for
mutational analyses of dPER homodimer functions (Met560Asp mutation) [66], are shown as atomic stick ﬁgures. (B) Domain organization and crystal structures of mouse
PERIOD 1,2,3 (mPER 1,2,3). Top: domain schematic of mPER proteins. Two PAS domains (PAS-A and PAS-B) are C-terminally followed by a CKI binding and phosphorylation site.
This region also contains the FASPS (familial advanced sleep phase syndrome) mutation site. The mammalian CRYs bind to the C-terminal region of the mPERs. Middle and
bottom: Crystal structures of mPER2 (middle), mPER1 and mPER3 (bottom) homodimers. mPER homodimers are mediated by antiparallel interactions of the PAS-B ß-sheet
surfaces including the conserved tryptophans Trp419 (mPER2), Trp448 (mPER1) and Trp359 (mPER3) corresponding to Trp482 of dPER. In the mPER2 structure, a nuclear
export signal (NES) in the aE helix, a nuclear receptor binding motif (LxxLL) in the ßE-strand of PAS-A, and a TrCP E3 ligase binding site for mPER2 degradation located C-
terminal to aE are labeled. In mPER1, the ß-TrCP interaction site is located N-terminal to PAS-A. mPER1 is stabilized by an additional PAS-A interface mediated by the aC
helices and has a well-structured N-terminal cap helix (aN). These features (aC interface, N-terminal cap) are partly also observed in mPER3, but are absent in mPER2.
Adapted from [59,58] and the PhD thesis of Ira Schmalen (2014). (C) Domain organization and structure of the CLOCK-BMAL1 heterodimer. Top and bottom: domain schematics
of CLOCK (top) and BMAL1 (bottom). CLOCK contains a N-terminal E-box-DNA binding bHLH (= basic Helix-Loop-Helix) domain, PAS-A and PAS-B domains, an unconventional
HAT (= histone acetyl transferase) domain and a polyQ (= poly glutamine) domain. The PAS-B domain of CLOCK is reported to interact with cryptochromes. BMAL1 contains a
bHLH domain, PAS-A and PAS-B domains and a C-terminal transactivation domain (TAD), which interacts with mCRY in an acetylation-dependent manner or with p300/CBP.
Middle: Crystal structure of the CLOCK-BMAL1 heterodimer [54]. CLOCK and BMAL1 are arranged in parallel such that each module (bHLH, PAS-A, PAS-B) interacts with its
counterpart in the dimerization partner. The conserved Trp427 in PAS-B of BMAL1 interacts with PAS-B of CLOCK, while the conserved Trp362 of CLOCK provides a binding
site for mCRY. The PAS-A and -B domains are arranged as in the mPER monomers in BMAL1, but differently in CLOCK. Adapted from PhD thesis of Ira Schmalen (2014).
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their DNA targets, transcriptional activity and transcriptional regu-
lators to be recruited. These functions in turn are mediated by the
N-terminal E-box-DNA binding bHLH domain or by transcriptional
activation domains located C-terminal to the PAS domains.
Mammalian CLOCK for example has a C-terminal glutamine rich
activation domain preceded by a histone acetyl transferase (HAT)
like domain, which is reported to acetylate Lys537 of its
heterodimerization partner BMAL1 in a daily rhythmic manner
[52] as well as histone H3 Lys14 [53]. BMAL1 Lys537 acetylation
enhances the recruitment of mCRY1 to the C-terminal region of
BMAL1 and thereby transcriptional repression [52]. Additionally,
mCRY1 is reported to bind to the PAS-B domain of CLOCK [54].
Release of the mCRY1 repressor from the BMAL1/CLOCK complex
allows for the binding of the HAT CBP/p300 to overlapping
C-terminal BMAL1 regions, which leads to transcriptional activa-
tion in a timely manner [55,46].
During the past decade, crystal structures of PAS domain frag-
ments of Drosophila PERIOD (dPER) [56,57] and the mousePERIOD homologs mPER1,2,3 [58,59] have been determined.
Furthermore, 3D structures of the bHLH-PAS domain regions and
the E-Box-DNA bound bHLH-domains of the mammalian
CLOCK/BMAL1 complex were reported [60,61]. These structures
shed light on the organization of the tandem PAS-A and -B domains
within PERIOD homodimers and the CLOCK/BMAL1 heterodimer as
well as suggest possible consequences of PAS-mediated dimeriza-
tion on molecule functions. While the domains themselves adhere
to standard PAS architecture, their arrangements within the dimers
are remarkably different (Fig. 2). In the following, results and
important biological insights gained from these clock protein crys-
tal structures will be discussed.
2.2. Structure and function of the dPER PAS domain homodimer
In the dPER homodimer structure, the PAS domains are
arranged in a head to tail conﬁguration such that PAS-A interacts
with PAS-B of the opposing subunit [56] (Fig. 2A). A loop of the
PAS-B b-sheet (connecting strands bD and bE) inserts a highly
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PAS-A of the dimerizing molecule. A second homodimer interface
is generated by an additional a-helix C-terminal of PAS-B named
aF, which – in its kinked conformation – packs against the PAS-A
ß-sheet surface of the dimerizing subunit [56]. Notably, this aF
helix is highly dynamic as it can associate with PAS-A with varying
helical registers [57] and also can adopt a stretched conformation
to completely dissociate from the PAS-A domain of the dimerizing
molecule [56]. Conformational dynamics of the aF helix are likely
to inﬂuence the functionality of C-terminal regions of dPER
including phosphorylation sites (see below) or the dCLK/CYC inhi-
bition domain (CCID) [62]. Interestingly, the aF helix directly con-
tacts the site of the perL (Val243Asp) long period mutation that is
located on the PAS-A-b-sheet surface within the PAS-A-aF
homodimer interface (Fig. 2A bottom). This mutation confers
temperature-sensitive phenotypes of clock period lengthening to
about 29 h [63], delayed nuclear entry of dPER [64] and reduced
dTIM binding [65]. Moreover, the perL mutation disrupts dPER
homodimers in vitro [56]. We therefore propose that the perL phe-
notypes are correlated with a destabilization of the dPER
homodimer, which, as we discuss below, plays an important role
in the ﬂy circadian clock. While the PAS-A b-sheet is covered by
the aF helix of the dimerizing molecule, the ß-sheet surface of
the PAS-B domain remains surface exposed (Fig. 2A). Analyses of
a triple mutant on the PAS-B b-sheet surface by analytical gel ﬁltra-
tion and yeast-2-hybrid experiments showed, that the PAS-B
b-sheet surface is involved in dTIM binding, but is not required for
dPER homodimer formation as the crystal structure suggests [59].
A comprehensive in vivo study with ﬂies expressing a mutant
dPER protein with a Met560Asp exchange in helix aF directly
opposite the perL site of the dimerizing molecule (Fig. 2A bottom),
established the role of the dPER homodimer in the ﬂy circadian
clock [66]. As suggested by the dPER structure, the Met560Asp
mutation reduced dPER homodimer formation in vitro and in the
ﬂy without affecting dTIM binding [59,66]. Reduced homodimer
formation coincided with a somewhat (approx. 1 h) longer period
length of the ﬂies’ behavioral rhythms, changes in PER nuclear
translocation and phosphorylation as well as reduced repressor
activity of PER toward dCLK:CYC [66]. Hence the dPER homodimer
is important for circadian clock function and the phenotypes of the
Met560Asp mutation are likely to arise from the weakening of the
PAS-A-aF dimer interface. Interestingly, the Met560Asp mutant
phenotypes mirror those of mutations in casein kinase 2 (CK2),
which phosphorylates dPER on residues 149 to 151 N-terminal to
PAS-A [67–70]. The more drastic period lengthening and
temperature-sensitive phenotype of the perL mutation in the same
interface is presumably due to the fact that perL not only weakens
the PAS-A-aF interface and hence homodimer formation [56], but
(in contrast to Met560Asp) also affects dTIM binding to PAS-A [65].
A second set of mutation sites leading to short period pheno-
types with period lengths of 16 h (perT, Gly593Asp) to 19 h (perS,
Ser589Asn) [63,64] is located just C-terminal to the ﬂexible aF
helix of dPER in a region referred to as short mutable (SM) region.
Interestingly, the SM region and the C-terminally adjacent so called
per-short downstream (Per-SD) region contain a number of phos-
phorylation sites that are critical for clock function, including the
perS site (Ser589) itself [29,71,72]. Sequential phosphorylation of
serine residues in the SM and Per-SD regions by ﬁrst the kinase
NEMO and then Doubletime (DBT) ultimately inhibits the DBT
dependent phosphorylation of yet another serine residue (Ser47)
located N-terminal to PAS-A. Phosphorylation of Ser47 in turn is
critical for the recruitment of the E3-ligase SLIMB that mediates
dPER degradation (Fig. 2A) [27–29]. Hence, this phosphorylation
cascade sets the clock’s pace by regulating dPER stability. The
dPER crystal structure suggests that conformational changes of
the aF helix between the kinked (PAS-A bound) and the stretchedstate (Fig. 2A) could inﬂuence or be affected by the phosphoryla-
tion state of the Per-SM and Per-SD regions, which are only 20
and 40 residues apart from the C-terminal end of the aF helix.
Furthermore we hypothesize, that homodimer formation and the
aF conformation could inﬂuence the efﬁciency of Ser47 phospho-
rylation and hence dPER stability [27] by modulating the distance
of the C-terminal SM- and Per-SD regions to the N-terminal Ser47
phosphorylation sites. Modeling studies based on the dPER homod-
imer structure support this possibility and suggest that the kinked
(PAS-A bound) aF conformation may be more efﬁcient in achieving
proximity of these phosphorylation sites. However, experimental
proof is still required.
Notably, the arrangement of phosphorylation sites in the Per-SD
region resembles that of the casein kinase Ie (CKIe) phosphoryla-
tion motif in human PERIOD2 (hPER2), that has been implicated
in the Familial Advanced Sleep Phase Syndrome (FASPS) (Fig. 2B)
[71]. FASPS is an autosomal dominant circadian rhythm variant
with a 4-h advance of sleep, temperature and melatonin rhythms.
FASPS is caused by a Ser662Gly mutation in hPER2, that prevents
CKIe dependent phosphorylation [73] and thereby also affects
PER2 stability and activity [73–75].
2.3. From ﬂies to mammals: structures of the mouse PERIOD 1,2,3 PAS
domain homodimers and functional insights
In mammals, three PERIOD homologs (mPER1, mPER2 and
mPER3) constitute central components of the circadian clock.
Their PAS domains (PAS-A and PAS-B) mediate homo- and hetero-
dimeric mPER-mPER interactions as well as interactions with the
transcription factors BMAL1/2, CLOCK and NPAS2 [76,55,77,78],
with kinases (e.g. CK2 [39], GSK 3b [40]) and with nuclear recep-
tors of different physiological functions [79]. Heme binding to
the PAS domains of mPER proteins has also been observed [80–
82,58] but is controversially discussed [83].
Crystal structures of PAS domain homodimers of all three mPER
homologs have been determined [59,58] (Fig. 2B). Different from
the head-to-tail arrangement observed in dPER, the PAS domains
of all three mPER homologs stack in an antiparallel fashion via
their PAS-B b-sheet surfaces. Despite their different architecture,
the mPER homodimers also include the highly conserved trypto-
phan (Trp448mPER1, Trp419mPER2, Trp359mPER3) corresponding to
Trp482dPer as a central dimer interface residue. As in dPER
[56,59,66], mutation of the conserved tryptophan affects mPER
dimerization in vivo and in vitro [59,58]. Hence, the PAS-B
b-sheet surface of PERIOD turns out to be a versatile interaction
site which mediates mPER homodimerization in the mammalian
clock and dPER-dTIM heterodimer formation in Drosophila
[56,59]. Furthermore, modeling suggests, that mPER1/2/3 hetero-
dimers could also be formed via this PAS-B interface.
Due to somewhat changed relative orientations of the mPER
monomers, mPER1 homodimers are additionally stabilized by
interactions between the PAS-A domains via their long aC helices
(Fig. 2B). Furthermore, mPER1 and mPER3 have an N-terminal
cap helix (aN) N-terminal to their PAS-A domains, while the corre-
sponding region of mPER2 is unstructured. Biochemical analyses of
the PAS homodimer interfaces using analytical ultracentrifugation
revealed a ten times higher dimer afﬁnity for mPER1
(KD = 0.15 lM) compared to mPER2 (KD = 1.3 lM) and mPER3
(KD = 1.7 lM), likely due to the additional PAS-A homodimer inter-
face of mPER1 [58].
A functional role of mPER homodimers in the mammalian circa-
dian clock has been suggested by Fluorescence recovery after pho-
tobleaching (FRAP) experiments that observe the mobility of
multi-subunit MDa sized mPER-CRY containing complexes in
mammalian cell culture [58]. Apart from PER and CRY proteins,
these multi-subunit complexes contain various transcriptional
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nation [84–87]. mPER proteins are thought to contribute to tran-
scriptional feedback repression by delivering these complexes
and their intrinsic enzymatic functions to the DNA-bound
BMAL1/CLOCK complex to inhibit BMAL1/CLOCK activity via mul-
tifaceted and timely regulated mechanisms [87]. Interestingly,
FRAP experiments revealed, that mPER2 containing multi-subunit
complexes exhibit a faster mobility upon destabilization of the
PAS-B/tryptophan homodimer interface of mPER2 [58]. Hence,
PER2 homodimers appear to be relevant for the integrity of these
large and functionally important clock protein complexes.
Based on the relatively low homodimer afﬁnity of its PAS
domains, the higher ﬂexibility of its PAS-A domain and the
unstructured N-terminal cap, mPER2 seems to be more predis-
posed for heterodimeric signaling interactions than mPER1 and
mPER3. Consistently, the PAS domains of mPER2 but not mPER1
have been reported to bind to casein kinase 2 (CK2) [39], glycogen
synthase kinase 3b (GSK 3b) [40], REV-ERB and other nuclear
receptors [79]. Notably, mPER2 contains an LXXLL coactivator
motif typical for nuclear receptor binding in the ßE strand of
PAS-A, which is reported to be involved in mPER2 binding to
REV-ERBa and PPARa [79]. In mPER1 and mPER3, the correspond-
ing motifs contain sequence exchanges and moreover they are bur-
ied underneath the well-deﬁned N-terminal cap helices (aN) of
mPER1 and 3 (Fig. 2B, [58]). These structural features may correlate
with the reported inability of mPER1 to interact with nuclear
receptors [79]. Interestingly, the nuclear receptor binding motif
of mPER2 also plays a role in mPER2 nuclear import and nuclear
immobility [88], possibly by mediating binding to nuclear
receptors in the nucleus (effect on nuclear immobility) or in the
cytoplasm (effect on nuclear import).
dPER and mPER proteins have an extra aE helix C-terminal to
PAS-B which packs against the PAS-B core domain (Fig. 2A and B)
[56,59,58] and contains a Nuclear Export Sequence (NES) in all
three mPER homologs [89]. Due to the somewhat changed relative
orientations of the mPER monomers, the NES is engaged in homod-
imer contacts in mPER2 but not in mPER1 and mPER3. Homo- and
heterodimer interactions of the mPER proteins are therefore likely
to modulate the function of this NES in the circadian clock.
Different monomer orientations, homodimer afﬁnities and
N-terminal cap structuring may also correlate with the distinct
locations of the sites for the CKIe-dependent recruitment of the
E3 ligases b-TrCP1/2, that are responsible for mPER degradation.
The respective CKIe phosphorylation sites are located N-terminal
to PAS-A in mPER1 (residues 121–126, TSGCSS) and directly
C-terminal to the aE helix in mPER2 (residues 477–482, SSGYGS)
[41,42] (Fig. 2B).
2.4. Structure–function analyses of CLOCK/BMAL1 dependent
transcriptional regulation of the mammalian circadian clock
The crystal structure of the bHLH-PAS domain region of the
CLOCK/BMAL1 complex revealed a parallel head-to-head arrange-
ment of BMAL1 and CLOCK, where each module (bHLH, PAS-A,
PAS-B) interacts with its counterpart in the opposing subunit
(Fig. 2C) [54]. The N-terminal DNA binding bHLH motif recognizes
the palindromic E-box sequence [90]. The PAS-A domains swap
their N-terminally ﬂanking aA’-helices to interact with the
b-sheet surfaces of the PAS-A domains of the respective dimeriza-
tion partner, whereas the PAS-B domains of CLOCK and BMAL1 are
stacked in a parallel orientation. The PAS-B b-sheet of BMAL1 con-
tacts the helical face of the PAS-B domain of CLOCK using the
conserved Trp427BMAL1 (corresponding to Trp482dPER and
Trp419mPER2) as a central residue. In contrast, the b-sheet surface
of the PAS-B domain of CLOCK remains surface exposed and pro-
vides a binding site for mCRY1, including again the conservedtryptophan (Trp362 in CLOCK) as well as adjacent residues [76].
It is not clear yet, if PER proteins bind to the CLOCK/BMAL1 com-
plex via their PAS domains directly, and reportedly mCRY1 can
only associate with the DNA-bound CLOCK/BMAL1 complex in
absence of PER [91,92]. However, the two PAS domains of BMAL1
are arranged as in the PERIOD monomers, suggesting that
mPER/BMAL1 heterodimers with an mPER homodimer like archi-
tecture could potentially be formed. It has yet to be established
whether or not such direct mPER-BMAL1 interactions do occur in
the cell and if so, in which compartment and with which cellular
function.
Genome-wide analyses lead to a reﬁned picture of
BMAL1/CLOCK transcriptional regulation with three temporally
separated phases: (i) an early repressive state containing
multi-subunit CRY-PER complexes, that is observed between circa-
dian time (CT, see glossary) 12 and CT20 in mouse liver, (ii) a late
repressive state with an inactive DNA-bound BMAL1/CLOCK/CRY
complex (CT0 to CT4) and (iii) a transcriptionally active state in
which BMAL1/CLOCK recruits its coactivator p300/CBP (CT8)
(Fig. 1D) [93]. In this scenario, PER proteins contribute to the tran-
scriptional regulation of BMAL1/CLOCK by multifaceted mecha-
nisms including the recruitment of transcriptional regulators
within multi-protein CRY-PER complexes [87], the regulation of
BMAL1/CLOCK posttranslational modiﬁcations [94] as well as com-
peting interactions with mCRY1/2 [95–97] and possibly
BMAL1/CLOCK [78]. PER-CRY complex formation would on one
hand spatially interfere with and thereby delay the formation of
the late repressive DNA-bound BMAL1/CLOCK/CRY complex, but
on the other hand also have a positive impact on the availability
of CRY as a transcriptional repressor in the nucleus. The availability
of CRY is warranted by promotion of its nuclear entry as well as by
preventing binding of the E3 ligase FBXL3 and subsequent protea-
somal degradation [98,96,97,99]. Competing interactions are also
involved in the transition between the late repressive state and
the transcriptionally active state. Here, mCRY1 and CBP/p300 com-
pete for their common binding sites in the transcriptional activa-
tion domain (TAD) at the C-terminal end of the BMAL1 molecule
(Fig. 2C) [76,55,100,101]. mCRY1 binding to BMAL1/CLOCK is
thought to delay the formation of the transcriptionally active state
by preventing the binding of the coactivator CBP/p300 to BMAL1
[93].
2.5. A molecular mechanism for the repressive and acetylation
dependent mCRY1-BMAL1 interaction
CRYs are composed of a conserved photolyase homology region
(PHR) consisting of an N-terminal ab-domain and a C-terminal
all-helical domain as well as variable C-terminal extensions
referred to as tails (Fig. 3A and B) [102]. The PHR binds the cofactor
FAD (ﬂavine adenine dinucleotide) in the all-helical domain and –
in the related DNA repairing photolyases – a second light harvest-
ing antenna chromophore in a secondary pocket between the
all-helical and ab-subdomain [103].
In mammalian CRYs, the tails and the preceding C-terminal
helix of the PHR (a22 in mCRY1, see Fig. 3A) are involved in tran-
scriptional repression of the BMAL1/CLOCK complex [104]. In vivo,
repressive mCRY1 binding is enhanced by the acetylation of
BMAL1 at Lys537, which is daily rhythmic with a peak in the early
repressive phase and reportedly mediated by the heterodimeriza-
tion partner CLOCK [52]. De-acetylation of BMAL1-Lys537 is medi-
ated by Sirtuin1 (SIRT1), an NAD+-dependent enzyme which is
regulated in a circadian manner [44].
Murine cryptochromes interact directly with the BMAL1-TAD
via the conserved C-terminal helix of the PHR as well as
non-conserved epitopes in the CRY1 and CRY2 C-terminal tails
with KDs in the lM range (Fig. 3C right, G) [105]. The CRY binding
Fig. 3. Structural and biochemical analyses of mammalian cryptochrome interactions. (A) Domain organization of cryptochromes. The photolyase homology region (PHR)
consists of an N-terminal ab domain and a C-terminal a-helical domain including the functionally important C-terminal a22 helix, which precedes the non-conserved
regulatory tail. Adapted from [96]. (B) Crystal structure of the mCRY1-mPER2 complex suggests regulation by a jointly coordinated zinc ion and disulﬁde bond formation. Top:
Crystal structure of the mCRY1-PHR in complex with a C-terminal mPER2 fragment. mCRY1 is shown in cyan, mPER2 in orange. mPER2 winds around the all-helical
subdomain of mCRY1 contacting the C-terminal a22 helix and the lid/interface loop (red) and approaching the secondary antenna binding pocket. The mCRY1-mPER2
complex is stabilized by a jointly coordinated zinc ion (Zn). Ser71, which is phosphorylated by AMPK, is located well outside the CRY1-PER2 interface. Adapted from [96].
Bottom: Model of the suggested interplay between Zn binding and the breakage of an intramolecular mCRY1 disulﬁde bond upon mCRY1-mPER2 complex formation [96]. In
the apo-mCRY1 crystal structure, a disulﬁde bond was observed between Cys412 in the lid and Cys363 near the FAD binding pocket [95]. Zn binding stabilizes the reduced
mCRY1 state and thereby presumably facilitates mPER2 binding by enhancing the ﬂexibility of the lid/interface loop (Fig. 3F). Reactive oxygen species or cellular redox
equivalents could affect the formation of the disulﬁde bond within mCRY1 and indirectly inﬂuence the free cellular zinc concentration by affecting the redox state of zinc
coordinating cysteines of zinc storage proteins. Changes in the cellular redox or metabolic state may therefore modulate the stability of the mammalian CRY-PER complex and
thus transcriptional repression of CLOCK/BMAL1. The model was taken and adapted from the PhD thesis by Ira Schmalen (2014). (C) Mutually exclusive interactions of
mammalian CRYs with FBXL3, PER2 or BMAL1/CLOCK regulate their stability and transcriptional repression activity. Left: Interaction with the E3-ligase FBXL3 (magenta)
leads to ubiquitinylation and subsequent proteasomal degradation of CRY. FBXL3 occupies the FAD binding pocket of CRY with its C-terminal tail, but also binds to the C-
terminal helix of the CRY-PHR (a22 in mCRY1) and the lid/interface loop with its leucine-rich-repeat (LLR) domain [98]. Middle: PER2 (orange) also binds to the C-terminal
helix and the lid, but does not bind in the FAD binding pocket [96,97]. Due to vastly overlapping binding sites, FBXL3 and PER2 binding to CRY are mutually exclusive. PER
binding therefore stabilizes CRY by preventing FBXL3 binding. Right: The binding of PER and the CLOCK:BMAL1 complex are also mutually exclusive, because BMAL1 (green)
also binds directly to the C-terminal helix of CRY [105], potentially employing a predicted BMAL1 helical segment. While the C-terminal tail of CRY is not required for PER2
binding (middle, [96]) and only partly involved in FBXL3 binding (left, [98]), it is essential for CRY-BMAl1 interactions [105]. The C-terminal tail of mCRY1 appears to sense the
acetylation state of BMAL1[105]. Furthermore, PER proteins may interact with BMAL1, CLOCK or the BMAL1/CLOCK complex via their PAS domains, suggesting another level
of potential binding site competition. Moreover, mammalian TIMELESS (TIM) is reported to also interact with CRY via the C-terminal helix [145]. Adapted from PhD thesis by
Ira Schmalen (2014). (D) Superposition of the mCRY1-mPER2 and mCRY2-FBXL3 complex crystal structures. Due to their vastly overlapping binding sites, binding of FBXL3
(magenta) and mPER2 (orange) to mCRY is mutually exclusive [98,96]. mCRY1 (cyan) and mCRY2 (green) adopt practically identical conformations in their complexes.
Figure taken from [96]. (E) Close-up view of the zinc interface of the mCRY1-mPER2 complex. The zinc ion is jointly coordinated by Cys1210 and Cys1213 of mPER2 (orange)
and Cys414 and His473 of mCRY1 (cyan). Cys412 of mCRY1, which is located in the vicinity of the zinc interface, forms a disulﬁde bond to Cys363 in apo-mCRY1 [95], but not
in the mCRY1-mPER2 complex. Figure taken from [96]. (F) Close-up view of the FAD binding pocket of the mCRY1-mPER2 complex. The FAD-binding pocket, the lid/interface
loop and the zinc interface of the mCRY1-mPER2 complex (cyan/orange) are shown. The apo-mCRY1 structure (gray, [95]) and FAD from the mCRY2-FAD complex (red, [98],
PDB entry ID 4I6G; mCRY2 protein not shown for clarity) are superimposed. Upon mPER2 binding, the lid undergoes a conformational change. The Cys412-Cys363 disulﬁde
bond is observed in the apo-mCRY1 structure, but not in the mCRY1-mPER2 complex. Figure taken from [96]. (G) Regulation of mCRY1-BMAL1 interaction by acetylation of
Lys537BMAL1. Top: In its non-acetylated state, Lys537 masks negative charges in BMAL1 through intramolecular interactions and thereby interferes with mCRY1 binding.
Bottom: Upon acetylation of Lys537, BMAL1 adapts an open conformation rendering its negative charges accessible for electrostatic interactions with positively charged
residues predominantly in the mCRY1 tail region. Therefore, the interaction of mCRY1 with acetylated BMAL1 is stronger than with non-acetylated BMAL1. Adapted from
[105].
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interact with the C-terminal helix of the CRY-PHR (Fig. 3C right).
Interestingly, an acetyl-mimetic mutation of Lys537 to glutamine
(Lys537Gln) increases the afﬁnity of BMAL1 to the mCRY1 tail,
but not to the mCRY2 tail or the C-terminal CRY helix [105] sug-
gesting that the tail of CRY1 speciﬁcally senses the BMAL1 acetyla-
tion state. Distinct BMAL1 interactions of the CRY1 and CRY2 tails
may, apart from their deviating sequences, also arise from the factthat the CRY2 tail is phosphorylated within the BMAL1 binding epi-
tope [106]. It will be interesting to ﬁnd out, how these unique fea-
tures of the CRY1 and CRY2 tails correlate with the non-redundant
physiological roles of the two mammalian CRY homologs sug-
gested by knock-out studies [32–34].
Notably, CRY1 binding to the overall negatively charged
C-terminal BMAL1 TAD fragments appears to depend on
electrostatic interactions with positively charged CRY1 residues
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negative charges in BMAL1 through intramolecular electrostatic
interactions. Lys537 acetylation may therefore enhance CRY1 bind-
ing by unmasking negatively charged BMAL1 residues for interac-
tions in particular with positively charged residues in the
regulatory CRY1 tail epitope [105]. Notably, the presence of the
PHR increases the afﬁnity of mCRY1 to BMAL1 about ten times
compared to mCRY1 fragments that only include the C-terminal
helix of the PHR and the tail [95]. Circular dichroism (CD) spec-
troscopy suggests that the PHR leads to an enhanced structuring
of the CRY1 tail, which likely contributes to the increased BMAL1
afﬁnity. However, the PHR does not appear to affect the inﬂuence
of the acetyl mimetic Lys537Gln mutation on CRY1 binding
[105,95]. It remains to be investigated whether the PHR of CRY1
also interacts with the BMAL1 TAD directly.
2.6. mCRYs as transcriptional repressors – from structure to function
Having discussed the tails of the mammalian cryptochromes
before their PHR core domains, we have technically put the cart
before the horse. Are the PHR core domains really only there to sta-
bilize or structurally reorganize the CRY tails? Certainly not.
Despite their high degree of sequence and structural conservation
also with respect to the related DNA repairing photolyases
[107,103], distinct variations between the PHRs deﬁne the differ-
ent roles of CRYs as blue-light photoreceptors (e.g. in insects and
plants), transcriptional repressors (e.g. in vertebrates) [102] or as
magnetoreceptors [108]. CRY-dependent magnetoreception has
e.g. been reported in migratory birds [109,110], in the migratory
monarch butterﬂy Danaus plexippus [111], in D. melanogaster and
in plants [112,113]. Different CRY functions also correlate with
their varying afﬁnities to the FAD cofactor. While photoreceptor
CRYs stably incorporate the FAD cofactor for blue-light absorption
[114,115], the afﬁnity of FAD to puriﬁed mammalian CRYs is much
lower (in the micro molar range) [98], likely due their more open
FAD binding pocket [95,98]. However, the crystal structure of
FAD-bound mouse CRY2 showed, that FAD binds to CRY2 in a prac-
tically identical position as in plant and Drosophila 6-4-photolyases
and photoreceptor type cryptochromes (Fig. 3F) [98,116–
119,95,120]. Although mammalian CRYs have been shown
to undergo photoreduction and to display light-dependent
magnetoreceptor functions in a cellular environment [121,122],
the biological role of FAD in the context of the mammalian CRYs
is under debate. Interestingly, the crystal structure of the
CRY2-FBXL3-SKB1 complex revealed that the C-terminal tail of
the E3 ligase FBXL3 binds to the FAD binding pocket of CRY2
[98]. Moreover, a period-lengthening carbazolic compound
(KL001) was identiﬁed in a chemical screen, which competes with
FAD binding and stabilizes CRY1 by inhibiting ubiquitination [20].
The co-crystal structure of the CRY2-PHR with KL001 revealed that
this compound indeed binds to the FAD binding pocket overlap-
ping with the isoalloxazine ring of FAD as well as the FBXL3
C-terminal tail [123]. Thereby KL001 is thought to act as a mimetic
of the FAD cofactor that interferes with FBXL3 binding and hence
proteasomal degradation of CRY.
In addition to the interactions of the FBXL3 tail in the FAD bind-
ing pocket, the leucine-rich repeat (LRR) domain of FBXL3 associ-
ates with the C-terminal helix of the CRY-PHR and with a loop
referred to as interface loop or C-terminal lid, which is located
between the FAD binding pocket and the C-terminal helix
(Fig. 3C left, D) [98]. The crystal structures of CRY1 [96] and
CRY2 [97] in complex with a C-terminal CRY-binding PER2 frag-
ment revealed that PER2 covers extensive surface regions of the
CRY PHR including also the C-terminal helix and the lid
(Fig. 3B and C middle). Hence, PER2 and FBXL3 binding to CRY is
mutually exclusive due to their vastly overlapping binding sites(Fig. 3D). PERIOD proteins can therefore stabilize CRYs by protect-
ing them from FBXL3 binding and subsequent proteasomal degra-
dation. As we discussed earlier, the C-terminal helix of CRY1 and
CRY2 is also involved in direct interactions with the BMAL1 TAD
and in transcriptional repression [105,95], suggesting an additional
level of binding site competition between PER and the
BMAL1/CLOCK complex (Fig. 3C right, G). Different from FBXL3,
PER2 does not occupy the FAD pocket, implying that FAD could still
bind to the PER-CRY complex (Fig. 3F). As suggested by the high
level of conservation of the CRY-PER interface residues, almost
identical interactions are observed in the CRY1-PER2 and
CRY2-PER2 complex structures [96,97]. Notably, neither FBXL3
nor PER2 bind nearby Ser71 (Ser89 in CRY2) [98,96,97] implying
that Ser71 phosphorylation by AMPK affects PER2 and FBXL3 inter-
actions and thereby CRY stability [35] by an indirect mechanism.
Mutational analyses of CRY in and around the secondary pocket
that binds the antenna chromophore in DNA repairing photolyases
showed, that this part of the CRY-PHR affects PER2 and FBXL3
binding as well as BMAL1/CLOCK transcriptional repression activ-
ity in mammalian U2OS or HEK293 cells. Further, it impacts on cir-
cadian bioluminescence rhythms in mouse embryonic ﬁbroblast
(MEF) cells [95,97,124]. In mammalian CRYs, this molecule region
therefore appears to play light and presumably cofactor indepen-
dent roles in circadian clock regulation, likely by affecting CRY sta-
bility and transcriptional repression activity. While PER2
approaches the secondary pocket with somewhat different confor-
mations in the CRY1 and CRY2 complex structures [96,97], FBXL3
does not [98].
Interestingly, the CRY1-PER2 and CRY2-PER2 complexes are
both stabilized by a zinc ion that is jointly coordinated by two cys-
teine residues of PER2 (Cys1210, Cys1213) as well as a histidine
and a cysteine residue of CRY (His473 and Cys414 in CRY1)
(Fig. 3B, C and E) [96,97]. Mutation of any of the zinc coordinating
residues signiﬁcantly weakens CRY1-PER2 complex formation in
mammalian cell culture by reducing the incorporation of zinc
[96]. Moreover, transgenic mice which constitutively overexpress
CRY1 with a Cys414Ala mutation in the zinc interface, show a
28 h long free-running period of locomotor activity, abnormal
entrainment behavior and symptoms of diabetes including
reduced b cell proliferation and insulin secretion
(hypo-insulinemia) [125–127]. Hence, zinc-dependent CRY1-PER2
complex formation appears to be important for circadian dynamics
and metabolic regulation. Since PER binding to the C-terminal CRY
helix is expected to interfere with CRY binding to BMAL1 (see
above), it is conceivable, that weakening of the CRY-PER interac-
tion by disruption of the zinc interface enhances the repression
activity of the CRY(Cys414Ala) mutant protein toward
BMAL1/CLOCK. This interpretation is consistent with the results
of circadian rescue experiments in CRY deﬁcient MEF cells, where
the Cys414Ala mutation leads to a blunted bioluminescent rhythm
amplitude of a Per-dLUC reporter gene [97]. Furthermore, the
metabolic phenotypes of the Cys414Ala mutant mirror those of
BMAL1 and CLOCK mutations that weaken the transcriptional acti-
vators and also lead to hypo-insulinemia and tissue-speciﬁc insulin
resistance [128].
In the apo-CRY1 crystal structure, Cys412 adjacent to the zinc
coordinating Cys414 in the lid/interface loop forms an intramolec-
ular disulﬁde bond to Cys363 located near the FAD binding site,
which is broken in the CRY1-PER2 complex structure
(Fig. 3E and F) [95]. Despite its location in the reducing cytosolic
and nuclear cellular compartments, CRY1 indeed also forms disul-
ﬁde bonds in mammalian cells, suggesting that the Cys412-Cys363
disulﬁde bond may play a role in vivo [96]. Comparison of the
apo-CRY1 and CRY1-PER2 complex structures suggests that reduc-
tion of the disulﬁde bond facilitates PER2 binding by enhancing the
ﬂexibility of the lid allowing for the conformational changes that
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unexpectedly, the individual mutations of the disulﬁde bond form-
ing cysteines of CRY1 neither affected transcriptional repression
activity [97] nor PER2 binding. However, their combination with
mutations of zinc coordinating cysteines partially rescued the
effect of the loss of the zinc ion on CRY1-PER2 interaction strength
in mammalian cell culture [96]. This observation led us to propose
that zinc stabilizes the CRY-PER complex not only by providing an
extra dimer interface but also by facilitating reduction of the
Cys412-Cys363 disulﬁde bond that anchors the lid to the FAD bind-
ing pocket. This hypothesis is supported by LC-ESI/MS mass spec-
trometry performed on puriﬁed CRY1-PER2 complexes, which
detected disulﬁde bond formation in CRY1 as a 2 Da mass differ-
ence. Zinc depletion of the CRY1-PER2 complex by addition of
EDTA or mutation of zinc binding residues signiﬁcantly enhances
CRY1 oxidation [96]. Although Cys412 and Cys363 are conserved
in CRY2 (Cys430 and Cys381 in mCRY2), no intramolecular disul-
ﬁde bonds have been observed in the CRY2 crystal structures
[98,97]. Instead, Cys430 of mCRY2 forms an intermolecular disul-
ﬁde bond to FBXL3 in the CRY2-FBXL3 complex structure [98].
Hence, Cys412 of mCRY1 and Cys430 of mCRY2 both show
enhanced redox reactivity, but display distinct redox sensitivities
in the apo-CRY1 and apo-CRY2 proteins. A complete understanding
of the functional roles of disulﬁde bond formation in CRY1 and
CRY2 requires further in vivo and in vitro analyses, which will be
guided by the available mammalian CRY crystal structures.
Changing cellular redox states have been shown to affect circa-
dian rhythms in a number of organisms ranging from cyanobacte-
ria to mammals. In cyanobacteria, the ratio of oxidized to reduced
quinones is involved in clock resetting by affecting the activity of
the clock protein KaiA [129]. Here, the accumulation of oxidized
quinones at the onset of darkness inhibits KaiA activity and
thereby phosphorylation of KaiC. In the fungus Neurospora crassa,
reactive oxygen species (ROS) are produced in a circadian manner.
Fluctuating ROS concentrations regulate the activity of the
WHITE-COLLAR transcription factor complex of the Neurospora cir-
cadian clock and affect circadian conidiation banding [130]. In
mammalian SCN slices, the relative redox state has been measured
from the ratio of auto-ﬂuorescence emissions of oxidized FAD and
reduced NAD(P)H using redox ﬂuorometry. The redox state was
shown to cycle in a circadian manner in SCN slices dependent on
the presence of a functional molecular clock [61]. It remains to
be investigated if and to what extent free zinc concentrations vary
in a circadian manner. We propose that zinc binding and disulﬁde
bond formation in CRY1 may provide an input pathway of these
parameters (cellular zinc concentration as well as redox and meta-
bolic state) to the core circadian oscillator by regulating
CRY1-PER2 complex formation and thereby CRY1 stability and
transcriptional repressor activity. The nanomolar KD determined
for zinc binding to the CRY1-PER2 complex [96] is within the range
of free cellular zinc concentrations [131], suggesting a regulatory
potential of zinc dependent CRY1-PER2 complex formation.
Interestingly, cysteine oxidation states changing in an circadian
manner in the H2O2 scavenging peroxiredoxins have been discov-
ered as non-transcriptional circadian oscillators, which are con-
served from cyanobacteria to mammals [132–135]. Furthermore,
ROS have been reported to oxidize and induce disulﬁde bond for-
mation of reactive cysteine residues within reducing cellular com-
partments in order to regulate the activity of proteins (e.g.
transcription factors, chaperones, signaling proteins) operating in
oxygen defense or signal transduction pathways [136]. Changing
ROS concentrations may therefore indirectly or even directly inﬂu-
ence the oxidation state of the disulﬁde bond forming CRY1 cys-
teine residues to modulate CRY1 activity in the mammalian
circadian clock. We also speculate about a role of FAD in modulat-
ing the redox state of the Cys363-Cys412 disulﬁde bridge in CRY1or the CRY1-PER2 complex. Since Cys363 faces the FAD binding
pocket of CRY1 (Fig. 3F), such an interplay seems possible. This
would imply that in mammalian CRYs (or at least in CRY1) FAD
may act primarily as a redox signaling partner/cofactor rather than
as light-sensor as in photoreceptor type cryptochromes (see next
section).
Finally we would like to emphasize, that zinc binding to the
CRY-PER complex and disulﬁde bond formation in CRY1 were
entirely unexpected and unpredictable ﬁndings uncovered only
by determining high resolution 3D crystal structures. On one hand,
this unexpected structure-based discovery demonstrates the great
impact that structural biology can have and has already had on the
advance of molecular circadian research. On the other hand, it
shows that the ﬁeld should be open for yet undiscovered and alter-
native input pathways that could link the cell’s metabolic and
redox state to the circadian clock.
2.7. Back to the ﬂies: Drosophila Cryptochrome as a circadian blue-
light photoreceptor
Different from the mammalian CRYs, Drosophila Cryptochrome
(dCRY) is a blue-light sensitive circadian photoreceptor that medi-
ates synchronization of the circadian rhythm with the environ-
mental light–dark-cycle [137] and plays a role in
magnetoreception [113]. dCRY stably incorporates FAD, and
blue-light illumination leads to the conversion of oxidized FAD
(FADox, dark state) to an anionic FAD radical [114]. A cascade
of three highly conserved tryptophans (Trp342, Trp397, Trp420)
has been implicated in the electron transport required for FAD
photoreduction [121] (Fig. 4).
The short C-terminal tail of dCRY regulates the activity of the
PHR during light-synchronization of the ﬂy circadian clock.
Blue-light illumination somehow triggers a conformational change
of the regulatory tail that enables binding of dTIM as well as the E3
ligase Jetlag (JET) to the dCRY-PHR, which is prevented in the dark
(Fig. 4A) [138,31]. Subsequently, dTIM and dCRY are degraded in
the proteasome and thereby dTIM is sequestered from the tran-
scriptional feedback loop (Fig. 1B) [139,140,30]. The role of FAD
photoreduction and of the conserved tryptophans in the regulation
of tail conformational changes and dCRY signaling is controver-
sially discussed. Ozturk et al. [141] suggest, that FAD rather than
oxidized FAD represents the ground state and therefore a
light-excited form of the anionic FAD radical is assigned to the
signaling state. However, Vaidya and colleagues [142] report corre-
lations between the light-induced or chemical reduction of FAD
and subsequent conformational changes of the regulatory tail,
which are consistent with FADox being the ground state and
FAD the signaling state leading to dTIM degradation. In any case,
the cryb mutation (Asp410Asn) in the FAD binding pocket severely
affects the biological activity of dCRY, showing that an intact pro-
tein environment of the FAD cofactor is essential for dCRY function
in light-synchronization of the circadian clock [137].
Crystal structures of full-length dCRY [119,95,120] showed that
the regulatory C-terminal tail forms an a-helix that occupies the
position of the photolesion in DNA repairing photolyases.
However, the dCRY structure reported in 2011 [119] was deter-
mined from crystals that suffered from an unusual form of
non-merohedral twinning. This led to a two-residue frame shift
error in the functionally important regulatory tail and its preceding
linker as well as structural changes in tail adjacent loops including
the lid and other characteristic loops of the animal CRY/6-4 pho-
tolyase subfamily referred to as protrusion loop, phosphate bind-
ing loop and sulfur loop (Fig. 4C). Czarna and colleagues detected
these changes because they had independently determined the
2.35 Å crystal structure of a dCRY construct with a ﬁve residue
truncation in the protrusion loop (dCRYDloop, pdb entry 4JZY),
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sity maps [95]. Using the reﬁned dCRYDloop structure as a model,
they solved the structure of full-length wild-type dCRY (pdb entry
4K03) by molecular replacement [95]. The dCRY structure reported
by Zoltowski et al. in 2011 [119] (pdb entry 3TVS) was superseded
by a newly deposited dCRY structure (pdb entry 4GU5) reported by
Levy and colleagues [120], which is in full accordance with the
dCRY structures obtained by Czarna et al. [95].
Czarna and colleagues [95] validated the new insights gained
from the observed structural changes in the tail and its adjacent
loops by extensive mutational analyses, which clearly shows the
originality and independent motivation of their work. In particular,
Phe534 (instead of Trp536) was identiﬁed as a residue, which
anchors the tail to the PHR and assumes the same location as the
6-4-photolesion in DNA repairing photolyases (Fig. 4C). In addition,
Glu530 and Ser526 anchor the tail to the PHR through extensive
hydrogen bonding networks [95] and are essential for
light-induced dCRY-dTIM and dCRY-dPER interactions [143].Fig. 4. Structure–function analyses of the phototransduction mechanism of the circad
conformational changes of the dCRY tail. Upon blue-light detection by the FAD cofactor,
enables binding of dTIM and the E3 ligase JETLAG (JET). That, in turn, will trigger proteas
Photoreaction of FAD in dCRY. FAD in its oxidized form is prevalent in the dark and is co
[114]. (C) Crystal structure of full-length dCRY suggests sulfur gated FAD photoreductio
oxidized FAD via a cascade of three conserved tryptophanes (Trp342, Trp397, Trp420) is g
Met331 nearby Trp342). Cys523 in the linker preceding the regulatory tail may sense
tryptophanes collapsed the photo-reaction in vitro, whereas mutation of Cys416, Cys33
Cys337 and Cys523 additionally speeded up photoreduction [95]. Residues Ser526, Glu53
dCRY structure reported in [119] (3TVS, beige) reveals a two-amino-acid frameshift throu
loops and different FAD conformations. Due to the 2-residue frame shift in the tail and
displaced in the 3TVS structure, Trp536 (instead of Phe534) is positioned in the loc
phosphorylated residue. Figure taken from [95]. (D) Electrostatic surface potential of dCR
divided into predominantly positively (blue) and negatively (red) charged regions. The ta
extends the charged dCRY surface regions, which may facilitate electrostatic interaction
sulfur-, phosphate binding- and protrusion loops is labeled for orientation. Adapted fromStructural changes in the sulfur loop locate its conserved cysteine
(Cys337) next to the middle tryptophan (Trp397) and its conserved
methionine (Met331) near the outer tryptophan (Trp342) of the
canonical electron transport cascade (Fig. 4C) [95]. The structure
therefore suggests that these electron rich cysteine and methion-
ine residues could gate the electron transfer via the tryptophan
cascade and thereby slow down the rate of FAD formation and
decay. This is conceivable, since electron ﬂux occurs along poten-
tial slopes, which are less steep within a cascade that is affected
by polarizable negative charges originating from close-by cysteines
or methionines. Mutational analyses support this model showing
that alanine substitution of Cys337 (near Trp397) or Cys416 (near
Trp420) indeed shortens the lifetime of the anionic FAD radical.
Moreover, correction of the 2-residue frame shift error places
Cys523 in the tail connector loop proximal to Met421, which is also
located close to Trp397 (Fig. 4C). As observed for Cys337, the
Cys523Ala mutation signiﬁcantly accelerated FAD formation
and decay, suggesting that Cys337, Cys523 and possibly Met421ian blue-light photoreceptor Drosophila Cryptochrome (dCRY). (A) Light-induced
the C-terminal tail of the cryptochrome undergoes a conformational change, which
omal degradation of dTIM and CRY, leading to light synchronization of the clock. (B)
nverted into the anionic FAD radical upon blue-light illumination. Adapted from
n. The dCRY structure reported in [95](dark blue) suggests that electron transfer to
ated by adjacent sulfur rich residues (Cys416 nearby Trp420, Cys337 nearby Trp397,
or affect electron transfer through Met421 located near Trp397. Mutation of the
7 and Cys523 decreased the dark recovery time of oxidized FAD and mutation of
0 and Phe534 anchor the tail to the dCRY-PHR [95]. Superposition of the full-length
ghout the tail, displacement of Cys337 due to altered conformations of tail adjacent
its preceding linker, critical residues like Cys523, Ser526, Glu530 and Phe534 are
ation of the photolesion in DNA-repairing photolyases and Thr518 is built as a
Y suggests binding sites for dTIM and JET. The molecule surface of dCRY can be sub-
il is depicted as stick presentation in yellow. Light-induced displacement of the tail
s with the acidic dTIM or the basic JET molecule. The location of the tail adjacent
[95].
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port chain and the regulatory tail [95]. Hence, cysteine reactivity
may also play a role in the light-dependent regulation of dCRY,
reminiscent of the proposed role of cysteines of mammalian
CRY1 in redox sensing (discussed above). Taking cysteine (and
potentially methionine) sulfur redox chemistry into account may
also help to resolve the controversial discussion about the roles
of FAD photoreduction and the classical tryptophan cascade in
dCRY function. Notably, in the full-length dCRY structures reported
by Czarna et al. [95] and Levy et al. [120] (pdb entries 4K03 and
4GU5), an intermolecular disulﬁde bond has been observed
between Cys296 in the protrusion loops of two adjacent dCRY
molecules. However, Berndt et al. have not observed disulﬁde
linked homodimers under gel ﬁltration conditions in solution
[114]. While dCRY crystal structures suggest an enhanced redox
reactivity of Cys296, a functional role of intermolecular disulﬁde
bond formation in dCRY remains to be identiﬁed.
The still open question remains how light-induced conforma-
tional changes of the tail regulate dTIM and JET binding to dCRY,
which ultimately leads to clock re-synchronization. Analyses of
the electrostatic surface potential of dCRY revealed, that the
dCRY molecule contains extensive positively and negatively
charged surface regions adjacent to the tail, which become even
more extended when the tail is removed (Fig. 4D) [95]. Since the
dTIM protein is acidic (theoretical pI = 5.17) and the JET protein
basic (theoretical pI = 8.54), we postulate that light-induced tail
displacement may facilitate dTIM and JET binding to dCRY by
removing steric clashes and by generating more extended surfaces
for electrostatic interactions.
In vitro and in vivo experiments using structure-based muta-
tions of the discussed cysteines and methionines or of residues
within the charged dCRY surface regions, would likely advance
our understanding of the phototransduction mechanisms underly-
ing dCRY-dependent light-synchronization of the Drosophila circa-
dian clock.
2.8. A ﬁnal note on Mammalian TIMELESS: a link between the
circadian clock, DNA replication and genome stability
In mammals, an orthologue of Drosophila TIMELESS was identi-
ﬁed by sequence homology. The mammalian TIMELESS (mTIM)
orthologue was shown to affect neuronal activity rhythms of the
circadian master clock in the SCN, periodicity of peripheral circa-
dian oscillators and DNA damage induced phase advances of circa-
dian clocks [144–146]. The mechanistic role of mTIM within the
circadian system could still not be stringently characterized, but
may at least partly be correlated with the reported interaction of
mTIM with mCRY1 [145]. Notably, mTIM binding to mCRY1 also
appears to involve the C-terminal helix of the mCRY1-PHR (a22)
that mediates binding of PER2, FBXL3 and BMAL1 as well as
BMAL1/CLOCK transcriptional repression (Fig. 3C) [145]. During
the past years, a number of literature reports have described vari-
ous roles of the mTIM orthologue in DNA replication, in particular
in the coordination of helicase and DNA polymerase activities or in
checkpoint signaling (reviewed e.g. in [147]). Collective evidence
therefore suggests that mammalian TIMELESS has acquired diverse
and partly interconnected functions in DNA replication, DNA dam-
age signaling and the circadian clock, presumably deﬁned by its
alternate molecular interactions with clock proteins (e.g. mCRY1)
or replication fork associated proteins. Furthermore, mTIM is
thought to provide a molecular link between the circadian clock
and cell cycle regulation.
As the ﬁrst 3D structural analysis of a TIMELESS protein, the
cryo electron microscopy structure and biochemical studies of a
complex of mTIM with its interaction partner Tipin (Timeless
interacting protein) and the replication protein A (RPA) hasrecently been reported [148]. This work has shed light on the 3D
architecture of the Timeless-Tipin-RPA complex and the regulation
of the recruitment of the mTIM-Tipin complex to the DNA replica-
tion fork via RPA conformational changes. Controlled recruitment
to different sites and machineries (possibly regulated in time and
space) is likely important to allow the multi-tasking mTIM protein
to fulﬁll its diverse functions.3. Conclusions and perspectives
The discussed 3D structures and structure-based studies of
Drosophila and mammalian circadian clock proteins have provided
important insights into fundamental mechanisms underlying cir-
cadian clock function. Crystal structures and protein biochemical
analyses of Drosophila (d) and mammalian (m) PERIOD proteins
as well as of the BMAL1/CLOCK complex have shed light on the reg-
ulation of the circadian clock by posttranslational modiﬁcations,
phosphorylation dependent degradation, cellular translocation
and speciﬁc interactions of clock proteins. Furthermore, the crystal
structures of the mammalian CRY2-FBXL3 and CRY1/2-PER2 com-
plexes illustrate how mPER2 and the E3 ligase FBXL3 bind to the
mCRY-PHR in a vastly overlapping manner to control mCRY stabil-
ity and nuclear translocation and thereby mCRY transcriptional
repression activity. Additionally, competitive binding of mCRY to
either mPER2 or BMAL1/CLOCK is likely to regulate the transition
from early to late repressive BMAL1/CLOCK complexes. The transi-
tion from the late repressive to the transcriptionally active state of
BMAL1/CLOCK is correlated with acetylation-dependent repressive
interactions of the mCRY1 regulatory tail with the BMAL1 TAD as
well as binding site competition with the transcriptional activator
p300/CBP.
Structure–function analyses of Drosophila and mammalian
cryptochromes suggest that cysteine chemistry may play a role
in the photoreaction and phototransduction of the dCRY circadian
photoreceptor and serve as a sensor for the cellular redox state in
mCRY1. Completely unexpectedly, the mCRY-PER2 complex struc-
tures revealed a jointly coordinated zinc ion in the mCRY-PER2
interface, that stabilizes this complex in mammalian cells struc-
turally and by facilitating reduction of an adjacent intramolecular
disulﬁde bond in mCRY1. Changing cellular redox and metabolic
states as well as ﬂuctuating free intracellular zinc concentrations
may therefore affect clock function by their impact on the forma-
tion and stability of the mCRY-PER2 complex. Consistent with
the additional role of mCRY1 in the regulation of glucose home-
ostasis [149,150], disruption of the zinc interface not only affects
clock function but also leads to diabetes symptoms in transgenic
mice. A small molecule compound (KL001), that leads to an
extended period length, stabilizes mCRY1 by displacing FBXL3
from its interaction site in the FAD cofactor binding pocket and
affects gluconeogenesis [20]. The now available crystal structures
of mammalian CRYs and their complexes with KL001, FBXL3, FAD
and mPER2 will guide the development of improved CRY chemical
probes and potentially of novel therapeutic modulators. Such com-
pounds could on one hand affect clock function in a directed man-
ner, and on the other hand be applied in the treatment of metabolic
disorders such as type II diabetes. Obviously, molecular chronobi-
ology has gone a long way from the identiﬁcation of Drosophila
PERIOD (dPER) as the ﬁrst clock gene in 1971 to a stage, at which
directions for the development of chemical interventions to clock
and metabolic disorders are becoming evident. Structural biology
has already had and will have a signiﬁcant impact on understand-
ing the underlying mechanisms and in guiding the rational design
of chemical modulators. Furthermore, increasing molecular
insights into circadian clock mechanisms and the connections
between circadian clocks, physiology and pathogenesis will help
T. Merbitz-Zahradnik, E. Wolf / FEBS Letters 589 (2015) 1516–1529 1527to extend the scope of potential therapeutic applications of com-
pounds that, like KL001, are primarily identiﬁed as clock modulat-
ing substances.
Wishful thinking?Well, maybe also your jetlag and unease hav-
ing worked odd hours could be cured by an uncomplicated treat-
ment in future!
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Glossary
Circadian time (CT): By convention, the onset of activity of diurnal organisms defines
circadian time zero (CT 0). The onset of activity of nocturnal organisms defines
circadian time twelve (CT 12)
CT 0: beginning of subjective day
CT 12: beginning of subjective night
